🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

👉 Biomarkers of lung congestion and injury in acute heart failure. Read all about it in #ESCHeartFailure bit.ly/3ySBifw EJHF Editor-in-Chief Jan Biegus #HFA_ESC Harriette Van Spall, MD MPH 🇨🇦 Shelley Zieroth Marat Fudim, MD MHS Gregg Fonarow MD Jozine ter Maaten Amr Abdin Giuseppe Galati Henry Han Wilfried Mullens

Being presented at #ESCCongress ⬇️ Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis hubs.li/Q02M1wzF0 European Society of Cardiology

In patients with heart failure and mildly reduced or preserved ejection fraction, finerenone resulted in a lower rate of total worsening heart failure events and death from cardiovascular causes than placebo. Full FINEARTS-HF trial results: nej.md/470x4ix #ESCardio

NHS Research Scotland opportunities for associate PI apprenticeships! Can here more about it at the trainee meeting in Perth

#CVCT2024 : NEW ! Submit your abstract for POSTER PRESENTATIONS → A special French “Wine & Cheese Poster Viewing Session” will be organized just after the keynote lecture on the evening of December 10th, at the peak attendance of CVCT. Find out more here: globalcvctforum.com/poster-present…

What’s new in #HF Oct 2024? doi.org/10.1002/ejhf.3… #Finerenone #FINEARTS-HF #FINE-HEART #Semaglutide #STEP-#HFpEF #SELECT #FLOW #MitraClip #RESHAPE-HF2 #MATTERHORN #Vutrisiran #HELIOS-B #Aficamten #SEQUOIA-#HCM #FOREST-HCM Pau Codina Verdaguer Daniela Tomasoni Alberto Aimo European Society of Cardiology Journals

#CVCT2024: "There are many cardiology meetings around the globe-both in person and virtually. But CVCT stands out as this is the meeting that most comprehensively covers cardiovascular medicine across the spectrum. And what do I mean by spectrum? Spectrum of past knowledge with..

Register now for the 2025 Heart Failure Hub Scotland annual Ensuring success with #HeartFailure conference Register here eventbrite.com/e/11th-annual-… Royal College of Physicians & Surgeons of Glasgow Leeanne Macklin

Our latest paper summarising evidence for subcutaneous furosemide in heart failure. academic.oup.com/ehjcvp/article…

Great discussions with great colleagues on current and future challenges of real world evidence, including pragmatic trials CVCT - CardioVascular Clinical Trialists #CVCT2024

It's a wrap up for the Day 1 of #CVCT2024 ! Brilliant discussions, friendships and moving the needle in clinical trials ! #CVCT #clinicaltrials #clinicalresearch

Cardiovascular trials still under-represent diverse groups relative to population disease distribution. In Nature Medicine, Otavio Berwanger, Harriette Van Spall, MD MPH 🇨🇦, and Faiez ZANNAD share insights on making clinical trials in this field more inclusive. Read more: buff.ly/48kV40B

Final clap for #CVCT2024 ! Thank you for 3 days of deep scientific discussions, inspiration and friendship ! Now, time for action ! #clinicaltrials #movingforward

EMPRESS-MI: Empagliflozin vs placebo, n=105 w/ LVSD (mean LVEF 34.8%) post-AMI (24wks): ↔️LVESVI, LVEDVI, LVEF, LAVI, LVMI ↔️NT-proBNP, hs-TnI ↗️Hct ↘️urate, weight 🔗 doi.org/10.1002/ejhf.3… Jaclyn Carberry Kieran Docherty Mark Petrie Colin Berry University of Glasgow Heart Failure Research Group UofG SCMH

Torsemide is proposed to have clinically important pharmacokinetic and pharmacodynamic advantages over furosemide. This study found no meaningful pharmacokinetic/pharmacodynamic advantages for torsemide versus furosemide. bit.ly/JASN0481 Cleveland Clinic Cleveland Clinic MD

🗞️ SUGAR-DM-HF #CMR estimated PCWP & congestion markers, and effect of #empagliflozin in #HFrEF with dysglycaemia European Society of Cardiology Journals Giuseppe Galati Amr Abdin Henry Han HFAPresident bit.ly/3C55VQt

📌Standardized Definitions of Changes in Kidney Function in Trials of #HeartFailure: JACC Journals Expert Panel From the #HFARC #CardioRenal #ClinicalTrials #HF #CKD

🚨 New HFA/ESC consensus statement! 🚨 Clinical management & therapy optimization for HFrEF patients with low BP—practical guidance for safer, more effective treatment. 📄👇 #HeartFailure ow.ly/IzyB50Va9rJ Amr Abdin Giuseppe Galati Henry Han Dr. Hadi Skouri EJHF Editor-in-Chief #EJHF

Age-specific troponin thresholds: considerations for the fifth universal definition of myocardial infarction in EHJ. doi.org/10.1093/eurhea… @ESCardio European Society of Cardiology Journals #age #5UDMI John William McEvoy

Join us tomorrow for the #HFA_ESC webinar: "Heart Failure in the Community" 📌 3 June 2025 | 18.00-19.00 CET 🎙️Faculty: Amina, Kieran Docherty, Maggie Simpson, Dr Klaus Witte MD 🔗 Register now: esc365.escardio.org/event/1974 European Society of Cardiology